KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,022 | -42.8% | 76,980 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $1,871,156 | -16.8% | 81,390 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $2,250,132 | +35.9% | 75,941 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $1,656,061 | +15.6% | 64,986 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $1,432,427 | +8.0% | 65,109 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,326,103 | -48.2% | 65,825 | +7.2% | 0.00% | -50.0% |
| Q1 2022 | $2,561,070 | +128.7% | 61,413 | +246.2% | 0.00% | +100.0% |
| Q4 2021 | $1,120,000 | +10.1% | 17,739 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $1,017,000 | +29.7% | 17,316 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $784,000 | +229.4% | 16,165 | +164.4% | 0.00% | – |
| Q1 2021 | $238,000 | -36.7% | 6,114 | +0.8% | 0.00% | – |
| Q4 2020 | $376,000 | – | 6,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |